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Leipzig, Germany.BACKGROUND Frequent premature atrial contractions and sick
sinus syndrome are primary causes of inappropriate atrial ﬁbrilla-
tion (AF) detection in insertable cardiac monitors (ICMs).
OBJECTIVE The study aimed to validate an algorithm designed to
reduce inappropriate AF detection on the basis of the identiﬁcation
of a single P wave during the cardiac cycle.
METHODS The original detection algorithm looks for evidence of
AF based on differences in the pattern of R-R intervals over a
2-minute period. The improved algorithm reduces evidence for AF
detection if P waves are detected. The algorithm was validated by
using Holter data, which collected 2 leads of surface electrocardio-
gram and continuously uplinked ICM electrocardiogram over a
46-hour period. ICM detections were compared with Holter anno-
tations to compute episode and duration detection performance.
RESULTS Valid Holter recordings (8442 hours) were analyzed from
206 patients. True AF was observed in 76 patients, yielding 482 true
AF episodes Z2 minutes in duration and 1191 hours of AF. The
algorithm correctly identiﬁed 97.8% of the total AF duration and
99.3% of the total sinus or non-AF rhythm duration. The algorithmDr Pürerfellner is a consultant for Medtronic BRC and has received
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minutes in duration, and 55% (78% per-patient average) of the
detected episodes had AF. AF was found in 95% of the detected
episodes41 hour. The improved algorithm reduced inappropriate
episodes and duration by 46% and 55%, respectively, while also
reducing appropriate episodes and duration by 2% and 0.1%,
respectively.
CONCLUSION An improvement in the ICM algorithm for AF
detection incorporating P-wave information substantially reduced
inappropriately detected episodes and duration, with minimal
reduction in sensitivity for detecting AF.
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Implantable devices with atrial leads to sense atrial rate have
been shown to have a high accuracy for the continuous long-
term detection of atrial ﬁbrillation (AF) episodes and
burden.1,2 In subcutaneous insertable cardiac monitors
(ICMs), PP intervals cannot be sensed reliably and hence
AF detection is performed using incoherence of R-R intervalsover a period of time.3 ICMs have been shown to have high
accuracy for the detection of AF burden,3,4 though not as
accurate as implantable devices with atrial leads. Intermittent
monitoring techniques using electrocardiograms (ECGs) and
Holter recordings are commonly used to search for AF and
corroborate symptoms. However, studies have shown poor
correlation between symptoms and occurrence of AF.5
The advantages of higher accuracy for diagnosing the
presence or absence of AF using implantable continuous
monitoring, particularly in patients with paroxysmal or
asymptomatic AF, compared with intermittent monitoring
using Holters6,7 may be reduced by the effort required to
adjudicate the episodes stored in the ICMs. The current ICMs
have an inappropriate episode detection rate of 1.7 per patient-
day,4 an impediment for using ICMs in patients with low
incidence of AF who will beneﬁt most from the use of ICMs.
At this rate, the effort required to properly identify AF may be
signiﬁcant and in some cases difﬁcult, given device memoryhttp://dx.doi.org/10.1016/j.hrthm.2014.06.006.
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after surgical AF ablation,7 catheter AF ablation,8–10 atrial
ﬂutter ablation,11 and cryptogenic stroke12,13 has been grow-
ing slowly. Increasing positive predictive value (PPV) of
episode detection may be an important factor to gain wide
acceptance of ICMs in these patient populations.
The majority of inappropriate AF detections in ICMs are
caused by runs of atrial ectopy with irregular coupling
intervals, sick sinus, and sinus arrhythmia.4,8,10 Moreover,
oversensing due to noise, bigeminal and trigeminal rhythms,
and sinus tachycardia with R-R variability; undersensing due
to small R waves; and oversensing due to T waves/P waves
may cause inappropriate detections in rare cases. In most cases
of inappropriate AF detection, the atrial activation is generated
by the sinus node or single atrial trigger (eg, atrial ectopy),
which is evidenced by a single P wave between 2 R waves.
The objectives of this study are to validate an improved AF
detection algorithm implemented in the Reveal LINQ ICM
(Medtronic Inc.), which uses evidence of a single P wave
between 2 R waves to reduce inappropriate detections, and to
compare it with the earlier version of the algorithm imple-
mented in the Reveal XT ICM (Medtronic Inc.).3,4Methods
Algorithm design
The AF detection algorithm based on R-R intervals3,4 looks
for patterns in a Lorenz plot of the difference in R-R intervalsFigure 1 Initial segment of a 2-minute detection period illustrating the P-wav
P-wave averaging every 4 beats that meet the rate and irregularity criteria.to compute an AF evidence score every 2 minutes. The AF
evidence score is compared against a threshold to detect AF.
In the improved algorithm, in addition to the R-R interval–
based AF evidence score, a P-wave evidence score is
computed and subtracted from the AF evidence score before
comparing it with the threshold in 4 steps: (1) The P-wave
evidence score is generated by averaging a 600-ms baseline
ECG window before R waves for 4 consecutive beats, which
meet rate and irregularity criteria (P-wave averaging;
Figure 1). (2) P wave, ﬂutter waves, and baseline noise are
identiﬁed from the morphological features (P-wave extrac-
tion algorithm). The P-wave evidence criterion is met if there
is a presence of a single P wave and absence of atrial ﬂutter
waves (multiple P waves) or noise in the averaged baseline
ECG. (3) P-wave evidence is accumulated over the 2-minute
detection interval to compute the P-wave evidence score
(P-wave evidence accumulation; Figure 1). (4) The P-wave
evidence score is used as evidence against the presence of
AF (AF evidence modiﬁcation; Figure 2). In the case of sick
sinus or runs of ectopy, the P-wave evidence score will be
high along with the R-R interval–based AF evidence score.
However, in the case of AF, only the AF evidence score will
be high.
The improved AF detection algorithm can work in a
“nominal” mode or in an “aggressive” mode. In the nominal
mode, the current R-R interval 4780 ms and the absolute
difference between the 2 most recent R-R intervals4100 ms
satisfy the rate/irregularity criteria for P-wave averaging. Thee evidence accumulation procedure. The inset illustrates the procedure for
Figure 2 Schematic for the combination of the P-wave evidence algorithm with the R-R interval–based AF detection algorithm. AF ¼ atrial ﬁbrillation;
ECG ¼ electrocardiogram.
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for P-wave averaging (current R-R interval4700 ms and no
irregularity criterion) to make the algorithm more speciﬁc for
AF detection. Also, evidence of bigeminy and trigeminy
rhythms, based on speciﬁc patterns in the Lorenz plot, is
subtracted from the AF evidence score in the aggressive
mode. Finally, the modiﬁed AF evidence score (Figure 2) is
compared with a threshold that can be set to 4 different
values consisting of “more sensitive,” “balanced sensitivity,”
“less sensitive,” and “least sensitive,” with the speciﬁcity of
the algorithm for AF detection increasing from the ﬁrst
setting to the last setting.Data set
The algorithm was initially developed and validated by using
a data set of 3330 detected AF episodes in 267 patients and
3219 detected AT episodes in 54 patients with the implanted
Reveal XT ICM in patients with syncope, cryptogenic
stroke, and history of AF.14 The detected episodes contained
only ECG from the ﬁrst 2 minutes of the episode and it is not
possible to determine how many true episodes were missed;
hence, duration detection performance and sensitivity could
not be evaluated. The more comprehensive validation
reported in this study, using a continuously stored Reveal
XT ICM ECG for 46 hours, was performed using Holter
recordings from the XPECT study.4 Patients were enrolled in
the XPECT study if they were scheduled to undergo
pulmonary vein ablation or surgical rhythm control inter-
vention or if they had undergone pulmonary vein ablationwithin the last 6 months and were still having symptoms
attributable to AF or if they had frequently documented AF
or frequent symptoms attributable to AF. In this study,
NorthEast Monitoring DR220 Holter recorders were used to
record 2 leads (leads II and III) of the patient’s surface ECG
as well as the ICM ECG digitized at 256 Hz that was
uplinked by using telemetry continuously for 46 hours. The
surface ECG in the Holter recording was annotated by an
independent core laboratory cardiologist for the occurrence
of AF. The resulting annotated Holter recording was
considered the truth (or gold standard) with respect to the
identiﬁcation of true and false AF detections by the ICM
device.
Holter recording segments with noninterpretable surface
ECG or ICM uplink telemetry errors were excluded from the
analysis. Noninterpretable segments were annotated by the
Holter reviewers as segments where they could not make an
annotation decision based on the available surface ECGs.
Telemetry dropouts leading to periods of no uplink and
storage of ICM ECG were also used to determine excluded
segments. A continuous loss of telemetry for more than 2
seconds or a total duration of telemetry loss for more than 10
seconds rendered a 2-minute detection period as an excluded
segment for telemetry errors. Segments annotated as atrial
ﬂutter were also excluded from the analysis.Statistical analysis
The Holter annotations for true AF episodes were compared
with the AF detections by using the ICM device as shown in
Figure 3 Deﬁnitions of true-positive, false-positive, false-negative, and true-negative duration used for the computation of episode and duration detection
performance metrics. AF ¼ atrial ﬁbrillation; FN ¼ false negative; FP ¼ false positive; ICM ¼ insertable cardiac monitor; NPV ¼ negative predictive value;
PPV ¼ positive predictive value; TN ¼ true negative; TP ¼ true positive.
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Z2 minutes in duration were used for data analysis. The
following performance metrics were evaluated: (1) Diagnos-
tic sensitivity, speciﬁcity, PPV, and negative predictive value
(NPV) of detecting the presence or absence of AF by using
the ICM device were evaluated for the duration of the Holter
recording period for each patient. (2) Duration detection
sensitivity, speciﬁcity, PPV, and NPV, a measure of accu-
racy of AF burden (cumulative AF duration per unit time),
were computed as shown in Figure 3 for the entire Holter
duration from all patients (gross) and for each patient and
then averaged across patients (patient average). (3) Gross and
patient average episode detection sensitivity and PPV were
computed as shown in Figure 3. Episode detection NPV and
speciﬁcity cannot be computed because a true-negative
episode cannot be deﬁned. Generalized estimating equation
estimates, which adjust for multiple episodes in a patient,
were also computed for episode detection sensitivity and
PPV. The results are reported for the nominal and aggressive
modes of the algorithm as well as for the 4 different
thresholds and compared with the original algorithm where
the P-wave evidence algorithm is not used.
The results of the algorithm are also summarized for
3 different “intention for usage” settings for the algorithm:
the non-AF setting, the AF-diagnosis setting, and the
AF-monitoring setting. In the non-AF setting, the AF
detection algorithm will be used in patients with the ICM,
where the probability that the patient has AF is low and
detecting AF is not critical, for example, in patients withsyncope. In the AF-diagnosis setting, patients are suspected
to have AF and the ICM will be used to diagnose whether the
patient indeed has AF, for example, in patients with
cryptogenic stroke. In the AF-monitoring setting, the patient
had a history of AF, that is, has a high probability of having
AF, and the ICM is used to evaluate whether the patient has
AF as well as when and how much AF the patient has to
make treatment decisions, for example, pre– or post–AF
ablation. The parameter values for P-wave evidence algo-
rithm and the detection threshold in these 3 settings were
predetermined from the development data set in appropriate
patient cohorts and are presented in Figure 2.Results
The XPECT study enrolled a total of 247 patients. The
baseline characteristics of the enrolled patients were reported
earlier.4 Patients had a mean age of 57  10 years, and 165
(67%) were men. There was history of stroke or transient
ischemic attack in 25 (10%) of the patients, paroxysmal AF
in 227 (92%), persistent AF with successful cardioversion in
28 (11%), atrial ﬂutter in 58 (24%), and tachycardia-
bradycardia syndrome in 10 (4%). Holter recordings were
analyzed from 235 patients, of which 206 Holter recordings
were suitable for analysis after excluding Holter recordings
with o10 hours of analyzable ECG. After the exclusion of
recording segments with missing telemetry or uninterpret-
able surface ECG, a total of 8442 hours of valid recording
time was analyzed from 206 patients, yielding an average
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observed in Holter recordings in 76 of 206 patients included
in the data analysis, yielding a total of 482 true AF episodes
Z2 minutes in duration and 1191 hours of AF.
In the AF-monitoring setting, the algorithm identiﬁed
patients having AF in 73 of 76 patients (diagnostic sensitivity
of 96%) with AF in their Holter recordings. In 130 patients
with the absence of AF in their Holter recordings,
the algorithm also identiﬁed the patient to not have AF in
117 patients (diagnostic speciﬁcity of 90%). The algorithm
identiﬁed 86 patients with AF, of which 73 (diagnostic PPV
of 85%) were identiﬁed to have AF in their Holter recordings.
The algorithm identiﬁed the patient to not have any AF in 120
patients, of which 117 patients (diagnostic NPV of 98%) were
identiﬁed to not have any AF in their Holter recordings.
Figure 4A shows the gross average of duration detection
sensitivity and speciﬁcity, while Figure 4B shows the gross
average of episode detection sensitivity and PPV at different
settings of the algorithm. For the AF-monitoring setting, if
there are 100 hours of true AF then the algorithm detected
97.8 hours as AF (gross duration sensitivity of 97.8%), and if
there are 100 hours of normal sinus or other non-AF rhythms
then the algorithm inappropriately detected 0.7 hours as AF
(gross duration speciﬁcity of 99.3%). The overall duration or
AF burden accuracy, deﬁned as the total correctly identiﬁed
duration, is 99.1%. The algorithm, in the AF-monitoring
setting, detected 85 of 100 episodes of true AFZ2 minutes
in duration (gross episode sensitivity of 85.3%), and of every
100 episodes detected by the algorithm across patients, 55
had true AF (gross episode PPV of 54.5%). Furthermore, if
there are 100 patients with detected episodes, then at least 78Figure 4 (A) Duration detection sensitivity and speciﬁcity and (B) episode detec
operation of the P-wave evidence algorithm compared with the R-R interval–basedof those patients will have at least 1 episode with true AF
(patient averaged episode PPV of 78.2%).
Table 1 lists the duration detection sensitivity, speciﬁcity,
PPV, and NPV as well as the episode detection sensitivity
and PPV for the AF-monitoring, AF-diagnosis, and non-AF
settings. Table 1 also lists the result of the original R-R
interval–based algorithm, equivalent to the P-wave evidence
algorithm being turned “off,” for comparison. Furthermore,
it reveals the improvement in speciﬁcity provided by the
P-wave evidence algorithm with minimal loss in sensitivity
for AF detection in the AF-monitoring setting. A relative
reduction of 55% in inappropriately detected AF duration
was achieved in the AF-monitoring setting compared with a
relative reduction of 0.1% in the total amount of appropri-
ately detected AF duration (Figure 5A). Also, the total
number of inappropriately detected episodes was reduced
by 46% with a corresponding relative reduction of o2% in
the total number of true AF episodes that were detected
appropriately (Figure 5B). An example of an inappropriately
detected episode by the original R-R interval–based algo-
rithm, but rejected by the improved algorithm, is shown in
Figure 6. The non-AF setting provides the highest speciﬁcity
while still maintaining a reasonable amount of sensitivity for
AF detection.
The difference in episode detection PPV between the
gross (54.5%) and the per-patient average (78.2%) in the AF-
monitoring setting was primarily due to the presence of a
large number of falsely detected episodes in a few patients.
There were 28 patients (14%) who had Z1 inappropriate
detection with nearly 70% of the inappropriately detected
episodes occurring in 3 patients (1%) while 14 patients (7%)tion sensitivity and PPV as a function of the detection threshold and mode of
earlier algorithm (P-wave evidence “off”). PPV ¼ positive predictive value.
Table 1 Duration and episode detection performance results for the 3 intention for usage settings of the algorithm
Performance metrics
Original R-R interval–based
algorithm1
Algorithm settings based on the intention for usage
AF-monitoring AF-diagnosis Non-AF
Duration sensitivity (%)
Gross 97.9 97.8 97.6 95.5
Patient average 88.4 88.0 87.6 83.6
Duration speciﬁcity (%)
Gross 98.4 99.3 99.4 99.6
Patient average 91.8 92.5 92.2 92.9
Duration PPV (%)
Gross 91.0 95.7 96.4 97.7
Patient average 73.8 79.6 81.8 89.9
Duration NPV (%)
Gross 99.7 99.6 99.6 99.3
Patient average 92.0 92.0 92.0 91.7
Episode sensitivity (%)
Gross 86.7 85.3 84.4 75.9
Patient average 90.5 90.0 89.8 86.6
GEE estimate (95% CI) 90.6 (84.0–94.6) 89.7 (82.9–94.0) 89.4 (82.4–93.8) 85.0 (77.5–90.3)
Episode PPV (%)
Gross 38.9 54.5 61.3 85.2
Patient average 72.5 78.2 80.9 89.9
GEE estimate (95% CI) 72.5 (63.5–80.0) 78.2 (69.3–85.1) 80.9 (72.0–87.4) 89.9 (82.2–94.5)
Results for the original R-R interval–based algorithm are included for comparison.
CI¼ conﬁdence interval; AF ¼ atrial ﬁbrillation; GEE¼ generalized estimating equation; NPV ¼ negative predictive value; PPV¼ positive predictive value.
1Detection threshold set at “balanced sensitivity.”
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314 inappropriately detected episodes contributed to only 52
hours of detected duration with a median episode duration of
4 minutes. For all detected episodes (Z2 minutes in
duration), the “gross” episode PPV was 55% and it increases
to 72%, 83%, 90%, 93%, and 95% for detected episodesZ6,
10, 20, 30, and 60 minutes in duration, respectively. Thus, if
the algorithm detects an AF episodeZ1 hour in duration in aFigure 5 (A) Proportion of false-positive and false-negative duration and (B)
intention of usage settings using the P-wave evidence algorithm improvement compatient with a history of AF, it is 95% likely that the episode
is a true AF episode. All detected episodes Z4 hours in
duration were true AF episodes in this study.Discussion
The results of the improved algorithm for the AF-monitoring
setting can be summarized as follows: It appropriatelythe number of false-positive and false-negative episodes for the different
pared with the R-R interval–based earlier algorithm. AF ¼ atrial ﬁbrillation.
Figure 6 Example of an episode that was detected by the original R-R interval–based algorithm that is no longer detected by the improved algorithm using
evidence of P waves.
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total sinus or non-AF rhythm duration. In addition, falsely
detected episodes were reduced by 46% and falsely detected
duration by 55% without signiﬁcantly affecting true episodes
and true duration. Taking only AF episodes Z2 minutes in
duration, 85% (90% patient average) were correctly classi-
ﬁed. Finally, 55% of the detected episodes (78% patient
average) and 95% of the detected episodes Z1 hour in
duration had AF.
From a clinical standpoint, in the AF monitoring setting
intended for patients with a high incidence of AF, the AF
burden measure may be used, in conjunction with the
corroboration of AF from the stored ECG, as the improved
algorithm performs reasonably well in detecting AF and non-
AF rhythms accurately 499% of the time. Note that 1% is
equivalent to about 14 minutes of inaccurate burden detection
per day across all patients. Gross false-positive episode
detection rate, a measure of episode review burden, was
0.9, 0.7, and 0.3 per patient-day of monitoring for the AF-
monitoring, AF-diagnosis, and non-AF settings, respectively,
as compared with 1.7 per patient-day in the earlier version of
the algorithm. As mentioned earlier, 3 patients contributed to
most of the falsely detected duration and episodes and 86% ofthe patients had no false detects during the Holter monitoring
period. While the enhanced algorithm is improved compared
to earlier version of the algorithm and performs similar or
better than other ECG-based AF detection algorithms with
respect to comparable performance metrics,15 the accuracy of
AF burden, PPV for episodes, and false positive rate needs to
be improved further to make the algorithm as accurate as dual
chamber devices.1,2
The clinical goal of an AF detection algorithm in an ICM
is to determine whether the patient has AF and, in certain
applications, quantify the amount of AF the patient is having.
In addition, the ICM can provide the temporal characteristics
of AF burden, deﬁned as cumulative duration of AF per day,
which allows one to determine whether the patient is having
paroxysmal, persistent, or chronic AF. Also, the average
ventricular rate during the entire duration of detected AF
should be reported by the ICM to evaluate the adequacy of
rate control during AF. Several studies have reported the
relationship between the amount of AF, as measured by
implantable devices in patients with comorbidities, and the
increased risk of stroke16,17 and risk for heart failure
events.18 There is no consensus among studies16–18 regard-
ing clinically relevant duration of AF. However, all these
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relevant; thus, an AF detection algorithm in an ICM should
be accurate in estimating the amount of AF, or the
cumulative duration of AF (AF burden), as it is impractical
to store or review each and every episode of detected AF.
The goal of the AF detection algorithm presented in this
study has been to optimize the algorithm to obtain the best
possible AF burden accuracy, particularly in the AF-
monitoring setting, which unfortunately requires a reduction
in the PPV of episode detection. For applications in which
knowing the amount of AF is not quite as important as in
patients with syncope or cryptogenic stroke, one can use the
non-AF or the AF-diagnosis setting where the algorithm is
better optimized for increased episode detection PPV while
the accuracy of AF burden detection takes a lower priority.
The episode detection PPV, a measure of the number of
true episodes among all the detected episodes, is highly
dependent on the event rate. This is particularly relevant for
the interpretation of the AF detection algorithm results in the
context of an ICM device that is implanted in different patient
populations and has limited episode storage. The AF episode
detection PPV will be 0% by deﬁnition if the patient does not
have any AF because false detections are the only possibility,
whereas for patients with chronic AF, the PPV will be 100%
because true positives are the only possibility. For example, if
the ICM device is implanted in patients with syncope, the true
AF event rate will be less than 1% on any given day. Thus, in
patients with syncope it is better to choose the algorithm
parameters that provide high speciﬁcity in order to increase
episode detection PPV and thus improving the chances of
storing a true AF episode given the limited storage capacity in
the device. In contrast, in a patient population who underwent
AF ablation, as was the case in this study, the true AF event
rate was 33% and, as a result, the PPV for AF episode
detection is expected to be higher than in a patient population
with syncope. The 3 intention for usage settings (non-AF,
AF-diagnosis, and AF-monitoring) illustrate how the specif-
icity is highest for the non-AF setting, which is intended for
use in patients in whom the expected AF event rate is low. In
contrast, the sensitivity is highest for the AF-monitoring
setting where the expected event rate is much higher.
Although the intention for usage settings were derived from
a development data set from various patient cohorts, the
results reported in this study are derived from the available
Holter data in a patient cohort with AF and a high event rate
and hence the actual episode and duration detection PPV for
other patient cohorts with lower event rate will be much lower
in the non-AF and AF diagnosis algorithm settings.
Guidelines for post–AF ablation monitoring19 suggest
considering a 30-second episode as recurrence of AF. The
AF detection algorithm presented in this study collects
evidence over a ﬁxed period of 2 minutes and that was a
deliberate choice based on performance for 30-second vs
2-minute detection periods. Thus, it cannot reliably detect
AF episodes that are shorter than 2 minutes in duration.
During the 46-hour Holter monitoring period in this data set,
4 patients had 10 true AF episodes430 seconds in durationand with no episodes42 minutes in duration, of which only
1 shorter episode was detected. However, this limitation may
be offset by the circumstances in which each criterion is
applied. The 30-second criterion is intended to identify
patients with AF within a short observation window (24–
48 hours). ICMs use the 2-minute criteria on a continuous
long-term recording; thus, only patients with AF episodes
o2 minutes in duration at all times will be incorrectly
classiﬁed as “nonrecurrent” post–ablation AF by the ICM.
The P-wave evidence algorithm looks for evidence of P
waves in the absence of noisy baseline or ﬂutter waves. In
addition, it looks for the presence of a single P wave between
2 R waves and thus can only operate at ventricular rates where
the T waves from the previous cardiac cycle do not interfere
with the morphological processing in the current cardiac
cycle. The presence of high ventricular rates (80 beats/min
or higher), low-amplitude P waves, or a signiﬁcant amount of
baseline noise or a PR interval4300 ms can cause the P-wave
evidence algorithm to not work efﬁciently. In the residual
inappropriately detected 2-minute segments, 32% primarily
had high ventricular rates, 58% primarily had insigniﬁcant
evidence of P waves (low amplitude, long PR, or high baseline
noise), and the remaining 10% had a combination of reasons
why the improved algorithm still inappropriately detected
those segments. In the absence of P-wave evidence, the
algorithm reverts to the R-R interval–based algorithm, which
has also performed well in detecting AF burden.4
Study limitations
One of the primary limitations of this study is that the Holter
monitoring period was only 46 hours. Thus, some of the
results presented in this study may not apply for a longer
duration of monitoring. Speciﬁcally, the performance meas-
ures for detecting the presence or absence of AF in patients
will change as a function of monitoring duration. The longer
the monitoring duration, the more likely the device will
detect AF in a patient either appropriately or inappropriately.
The duration detection sensitivity and speciﬁcity as well as
episode detection sensitivity and PPV may still be applicable
for a longer duration of monitoring, assuming the AF event
rate stays similar for the duration of monitoring. Another
limitation of this study is that it does not address the ability of
the algorithm to detect atrial ﬂutter or atrial tachycardia as
there was not much atrial ﬂutter observed in the patients
included in the study. Finally, the results presented in this
study do not apply to AF episodes that are o2 minutes in
duration as only episodes Z2 minutes in duration were
included in the analysis because of the 2-minute detection
period used in the algorithm.
Conclusion
An improved algorithm that incorporates P-wave informa-
tion to reject inappropriately detected AF episodes by an
ICM algorithm based on R-R interval incoherence is
described and validated by using data from a Holter study.
This algorithm substantially reduces the inappropriately
1583Pürerfellner et al Improved AF Detection in Insertable Cardiac Monitorsdetected episodes and duration with minimal reduction in
sensitivity for detecting AF.
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